vs
Side-by-side financial comparison of First Seacoast Bancorp, Inc. (FSEA) and Relay Therapeutics, Inc. (RLAY). Click either name above to swap in a different company.
Relay Therapeutics, Inc. is the larger business by last-quarter revenue ($7.0M vs $4.0M, roughly 1.7× First Seacoast Bancorp, Inc.). First Seacoast Bancorp, Inc. produced more free cash flow last quarter ($329.0K vs $-235.9M).
Sterling Bancorp was an American regional bank holding company that owned Sterling National Bank. It merged into Webster Bank in February 2022.
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
FSEA vs RLAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.0M | $7.0M |
| Net Profit | $-87.0K | — |
| Gross Margin | — | — |
| Operating Margin | -3.1% | — |
| Net Margin | -2.4% | — |
| Revenue YoY | 20.6% | — |
| Net Profit YoY | 93.8% | — |
| EPS (diluted) | $-0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.0M | $7.0M | ||
| Q3 25 | $4.0M | $0 | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $3.5M | $7.7M | ||
| Q4 24 | $3.4M | $0 | ||
| Q3 24 | $3.3M | $0 | ||
| Q2 24 | $5.9M | $0 | ||
| Q1 24 | $3.2M | $10.0M |
| Q4 25 | $-87.0K | — | ||
| Q3 25 | $390.0K | $-74.1M | ||
| Q2 25 | $-545.0K | — | ||
| Q1 25 | $-603.0K | $-77.1M | ||
| Q4 24 | $-1.4M | — | ||
| Q3 24 | $44.0K | $-88.1M | ||
| Q2 24 | $2.0M | $-92.2M | ||
| Q1 24 | $-1.2M | $-81.4M |
| Q4 25 | -3.1% | — | ||
| Q3 25 | -5.2% | — | ||
| Q2 25 | -13.7% | — | ||
| Q1 25 | -17.9% | -1105.2% | ||
| Q4 24 | -23.5% | — | ||
| Q3 24 | -17.8% | — | ||
| Q2 24 | 35.6% | — | ||
| Q1 24 | -24.8% | -903.0% |
| Q4 25 | -2.4% | — | ||
| Q3 25 | 9.8% | — | ||
| Q2 25 | -14.1% | — | ||
| Q1 25 | -17.1% | -1003.6% | ||
| Q4 24 | -46.9% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 33.9% | — | ||
| Q1 24 | -36.1% | -813.3% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $0.08 | $-0.43 | ||
| Q2 25 | $-0.13 | — | ||
| Q1 25 | $-0.14 | $-0.46 | ||
| Q4 24 | $-0.31 | — | ||
| Q3 24 | $0.01 | $-0.63 | ||
| Q2 24 | $0.42 | $-0.69 | ||
| Q1 24 | $-0.24 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $63.5M | $567.1M |
| Total Assets | $599.3M | $621.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $91.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $93.5M | ||
| Q4 24 | — | $124.3M | ||
| Q3 24 | — | $152.4M | ||
| Q2 24 | — | $134.1M | ||
| Q1 24 | — | $152.9M |
| Q4 25 | $63.5M | $567.1M | ||
| Q3 25 | $63.2M | $607.7M | ||
| Q2 25 | $60.8M | — | ||
| Q1 25 | $61.2M | $721.1M | ||
| Q4 24 | $62.0M | $777.8M | ||
| Q3 24 | $65.8M | $838.9M | ||
| Q2 24 | $64.5M | $681.7M | ||
| Q1 24 | $64.7M | $745.8M |
| Q4 25 | $599.3M | $621.3M | ||
| Q3 25 | $609.6M | $670.0M | ||
| Q2 25 | $604.8M | — | ||
| Q1 25 | $592.6M | $799.4M | ||
| Q4 24 | $580.8M | $871.3M | ||
| Q3 24 | $601.8M | $930.1M | ||
| Q2 24 | $601.7M | $772.5M | ||
| Q1 24 | $576.5M | $841.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $449.0K | $-235.5M |
| Free Cash FlowOCF − Capex | $329.0K | $-235.9M |
| FCF MarginFCF / Revenue | 8.1% | -3370.0% |
| Capex IntensityCapex / Revenue | 3.0% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | $-622.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $449.0K | $-235.5M | ||
| Q3 25 | $661.0K | $-62.1M | ||
| Q2 25 | $-151.0K | — | ||
| Q1 25 | $573.0K | $-73.2M | ||
| Q4 24 | $-2.9M | $-249.1M | ||
| Q3 24 | $289.0K | $-75.1M | ||
| Q2 24 | $-1.4M | $-65.8M | ||
| Q1 24 | $-70.0K | $-50.3M |
| Q4 25 | $329.0K | $-235.9M | ||
| Q3 25 | $640.0K | $-62.1M | ||
| Q2 25 | $-154.0K | — | ||
| Q1 25 | $542.0K | $-73.6M | ||
| Q4 24 | $-3.3M | $-251.1M | ||
| Q3 24 | $264.0K | $-75.3M | ||
| Q2 24 | $-1.6M | $-65.8M | ||
| Q1 24 | $-81.0K | $-52.1M |
| Q4 25 | 8.1% | -3370.0% | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | 15.4% | -958.4% | ||
| Q4 24 | -99.0% | — | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | -26.5% | — | ||
| Q1 24 | -2.5% | -520.7% |
| Q4 25 | 3.0% | 5.9% | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.9% | 5.0% | ||
| Q4 24 | 11.0% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 0.3% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | 1.69× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.57× | — | ||
| Q2 24 | -0.70× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
